Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  T.ACB.WS.U | ACB

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Post by TopDog2on May 27, 2020 4:32pm
134 Views
Post# 31079925

Peltz again...

Peltz again...
try this again...some of the text was cut off the first attempt

---------------------------------------------------------------------

Peltz Exits Legg, Leaves $500k on the Table
By Joe Morris, Beagan Wilcox VolzMay 27, 2020 Comments (2)
 
Nelson Peltz’s Trian Partners has liquidated its entire stake in Legg Mason, earning nearly $500,000 less than it would have if it suck around until the Franklin Templeton deal closed.
 
The sale of 2.46 million shares took place last week, a year to the day after Trian disclosed its stake in Legg Mason and a week after the Baltimore-based firm's shareholders voted to approve Franklin’s $4.5 billion acquisition, according to a regulatory filing.
 
Trian cashed out at a weighted average price of $49.80, representing a price range of $49.78 to $49.84, the filing shows. Franklin is due to pay $50 per share when the deal closes in September.
 
The sale proceeds amount to nearly $122.4 million, versus just under $122.9 million at the $50-per-share price.
 
Trian is pocketing a hefty profit by any measure. Legg Mason’s shares traded at $34.66 when Trian disclosed the stake a year ago. Last week’s sale netted the activist fund more than $37 million.
 
 
Trian exited Legg Mason in order to deploy cash elsewhere, according to a spokeswoman for the firm.
 
“Trian monetized its entire stake in Legg Mason to provide for new positions,” Trian's spokeswoman says. 
 
Peltz and his Trian co-founder, Ed Garden, will continue to serve on Legg Mason’s board until the Franklin deal closes, the spokeswoman adds.
 
Legg Mason officials declined to comment.
Bullboard Posts